Valuation: Skinvisible, Inc.

Market Cap 1.09M 962K 911K 823K 1.55M 105M 1.57M 10.9M 4.2M 53.53M 4.1M 4.01M 172M P/E 2024
-3.02x
P/E 2025 -1.17x
Enterprise Value 6.87M 6.05M 5.73M 5.17M 9.75M 659M 9.88M 68.57M 26.39M 337M 25.79M 25.23M 1.08B EV / Sales 2024
376x
EV / Sales 2025 351x
Free-Float
96.48%
Yield 2024 *
-
Yield 2025 -
1 day+0.55%
1 week+0.55%
Current month+12.28%
1 month+12.28%
3 months-4.94%
6 months-49.48%
Current year-12.36%
1 week 0.2
Extreme 0.2021
0.2
1 month 0.2
Extreme 0.201
0.43
Current year 0.15
Extreme 0.154
0.49
1 year 0.14
Extreme 0.143
0.9
3 years 0.06
Extreme 0.055
0.9
5 years 0.06
Extreme 0.055
0.9
10 years 0.01
Extreme 0.012
16.5
Manager TitleAgeSince
Chief Executive Officer 77 1998-03-04
Director TitleAgeSince
Chairman 77 2009-11-09
Director/Board Member 53 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/31/23 Conversion

Responsable ventes & marketing

37,688,925 -
1/31/23 Conversion

Chief Executive Officer

42,897,105 -
1/31/23 Conversion

Responsable ventes & marketing

37,688,925 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%+0.55%+34.73%+188.71% 1.09M
-0.98%-0.47%-4.52%+1.04% 344B
-0.34%-0.28%+2.97%-3.62% 230B
-0.26%-1.57%-7.00%+1.68% 131B
-0.14%+0.43%+7.96%+21.96% 68.92B
0.00%+3.08%+19.92% - 46.32B
+0.82%-2.83%-24.77%-23.79% 45.64B
-0.47%+0.91%+9.86%-12.25% 34.4B
-0.85%-5.16%+6.37%-34.64% 34.14B
-0.51%+0.91%-20.71%-17.16% 32.92B
Average -0.20%-1.16%+2.48%+13.55% 96.78B
Weighted average by Cap. -0.49%-1.07%-1.63%-2.16%

Financials

2024 2025
Net sales 20K 17.61K 16.69K 15.06K 28.39K 1.92M 28.76K 200K 76.83K 980K 75.1K 73.46K 3.14M 20K 17.61K 16.69K 15.06K 28.39K 1.92M 28.76K 200K 76.83K 980K 75.1K 73.46K 3.14M
Net income -566K -498K -472K -426K -803K -54.24M -813K -5.65M -2.17M -27.73M -2.12M -2.08M -88.89M -1.06M -937K -888K -801K -1.51M -102M -1.53M -10.62M -4.09M -52.16M -4M -3.91M -167M
Net Debt 5.73M 5.04M 4.78M 4.31M 8.13M 549M 8.24M 57.17M 22M 281M 21.51M 21.04M 900M 5.78M 5.09M 4.82M 4.35M 8.2M 554M 8.31M 57.67M 22.19M 283M 21.69M 21.22M 908M
Logo Skinvisible, Inc.
Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals Inc., is a pharmaceutical research and development (R&D) company. The Company has developed and patented a polymer delivery system, Invisicare, and formulated over forty topical skin products. Its flagship product, Invisicare, is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. Invisicare is specifically formulated to carry water-insoluble active and certain cationic active ingredients in water-based products without the use of alcohol, silicones, waxes, or other organic solvents. It is also exploring opportunities in medical markets outside the dermatology market, such as obesity and other potential markets.
Employees
2
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. SKVI Stock